Theodore S. Lawrence
Radiation oncologist who developed adaptive liver radiotherapy and radiosensitising drug combinations.
Former chair of radiation oncology at Michigan; pioneered individualised adaptive radiotherapy for liver tumours and DNA-damage-response radiosensitisers.
| Title | Journal | Year |
|---|---|---|
| Individualized adaptive stereotactic body radiotherapy for liver cancer | Journal of Clinical Oncology | 2016 |
Pages like this
not linked directly; found by shared links- PersonCostas A. Lyssiotis
Shares University of Michigan Rogel Cancer Center, Pancreatic ductal adenocarcinoma.
- PersonAlbert C. Koong
Shares SBRT / SABR (stereotactic radiotherapy), IMRT / IGRT (modern external beam), Pancreatic ductal adenocarcinoma.
- InstitutionHokkaido University Hospital
Shares SBRT / SABR (stereotactic radiotherapy), IMRT / IGRT (modern external beam), Hepatocellular carcinoma.
- PersonTheodore S. Hong
Shares SBRT / SABR (stereotactic radiotherapy), Hepatocellular carcinoma, Pancreatic ductal adenocarcinoma.
- PersonLori J. Pierce
Shares University of Michigan Rogel Cancer Center, IMRT / IGRT (modern external beam).
- TrialPREOPANC-1 / PREOPANC-2
Shares IMRT / IGRT (modern external beam), Pancreatic ductal adenocarcinoma.
- TechnologyLattice and GRID radiotherapy
Shares SBRT / SABR (stereotactic radiotherapy), IMRT / IGRT (modern external beam).
- IdeaMake one-week radiotherapy the default in overloaded systems
Shares SBRT / SABR (stereotactic radiotherapy), IMRT / IGRT (modern external beam).